Abbott

YTD

ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

CEO

Robert B. Ford

CEORobert B. Ford

Employees

114,000

Employees114,000

Headquarters

Abbott Park, Illinois

HeadquartersAbbott Park, Illinois

Founded

1888

Founded1888

Employees

114,000

Employees114,000

ABT Key Statistics

Market cap

200.02B

Market cap200.02B

Price-Earnings ratio

30.10

Price-Earnings ratio30.10

Dividend yield

2.14%

Dividend yield2.14%

Average volume

12.75M

Average volume12.75M

High today

$113.72

High today$113.72

Low today

$111.38

Low today$111.38

Open price

$112.20

Open price$112.20

Volume

9.31M

Volume9.31M

52 Week high

$141.23

52 Week high$141.23

52 Week low

$105.27

52 Week low$105.27

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $113.11. The company's market cap stands at 200.02B, with a P/E ratio of 30.10 and a dividend yield of 2.1%.

During the trading session on 2026-02-11, Abbott(ABT) shares reached a daily high of $113.72 and a low of $111.38. At a current price of $113.11, the stock is +1.6% higher than the low and still -0.5% under the high.

Trading activity shows a volume of 9.31M, compared to an average daily volume of 12.75M.

The stock's 52-week range extends from a low of $105.27 to a high of $141.23.

ABT News

TipRanks 1d

Exact Sciences Faces Shareholder Lawsuits Over Abbott Merger

Exact Sciences ( (EXAS) ) has provided an update. On November 19, 2025, Exact Sciences agreed to be acquired by Abbott Laboratories, with Exact to become a who...

Simply Wall St 3d

Assessing Abbott Laboratories Valuation After New AFib Catheter And Pulsed Field Ablation Data

Advertisement Why Abbott Laboratories (ABT) is back on investors’ radar Abbott Laboratories (ABT) is drawing fresh attention after late breaking clinical data...

TipRanks 6d

Abbott announce new clinical data from AFib therapies studies

Abbott (ABT) announced new clinical data from two late-breaking presentations at AF Symposium in Boston that demonstrate the strong safety and efficacy of the c...

Analyst ratings

71%

of 31 ratings

Buy

71%

Hold

29%

Sell

More ABT News

Simply Wall St 6d

How Soft Guidance, Exact Sciences Deal, and Device Scrutiny Will Impact Abbott Laboratories Investors

In late January 2026, Abbott Laboratories reported revenue and profit guidance below Wall Street expectations, highlighted ongoing weakness in its pediatric nut...

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.